HomeNewsBusinessClosely monitoring business models, strategies of banks: RBI Governor

Closely monitoring business models, strategies of banks: RBI Governor

The governor said irrespective of the fact that liquidity is in surplus, the risk pricing of various loans being extended by banks has to be done diligently by banks themselves.

November 16, 2021 / 22:08 IST
Story continues below Advertisement
RBI Governor Shaktikanta Das (File image)
RBI Governor Shaktikanta Das (File image)

The central bank is closely monitoring the business models and strategies of banks, Reserve Bank of India Governor Shaktikanta Das said on Tuesday. He, however, clarified that the central bank's move is not intended at interfering in banks' commercial decisions, but it will red flag lenders if there is any risk building up.

At the RBI, we have started taking a closer look at the business models and strategies of banks. Take your commercial decisions, we will not interfere, but we will see what kind of vulnerabilities and what kinds of risks are building up, and our first priority would be to caution banks themselves, Das said at the SBI's Banking and Economic Conclave.

Story continues below Advertisement

ALSO READ: RBI's low interest rates will continue to support demand in Indian economy, says CLSA

He said the RBI's supervision is now almost on a real-time basis and is not an annual exercise anymore. Technology has enabled a more intensive look towards the supervision process. While banks take their commercial decisions, they should also factor in the available liquidity and also the kind of interest rate structures they are providing. These decisions should be taken based on prudent principles, he said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show